NCT06542835 Community Partnership for Telehealth Solutions to Convey Information and Enhance Care
| NCT ID | NCT06542835 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Arizona |
| Condition | Colorectal Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2024-07-31 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 6,000 participants in total. It began in 2024-07-31 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Non-randomized, two-arm stepped-wedge trial of a multi-level colorectal cancer screening intervention.
Eligibility Criteria
Inclusion Criteria: * Ages 45-64 * Eligible for colorectal cancer (CRC) screening * Current patients (seen in the clinic in the last 6 months) * Primary speaker of English or Spanish * Cell phone listed in Electronic Health Record (EHR) * No recent history of CRC screening * Resides in one of the neighborhoods included in the main trial Exclusion Criteria: * Colorectal disease (e.g., ulcerative colitis or colectomy) * Personal history of colorectal cancer * End-stage or life-threatening diseases * Known to be under hospice care * Living in a skilled nursing facility * Patients who decline research participation will be removed from the patient contact list
Contact & Investigator
Anne Escaron, PhD
PRINCIPAL INVESTIGATOR
AltaMed Health Services Corporation
Frequently Asked Questions
Who can join the NCT06542835 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 64 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06542835 currently recruiting?
Yes, NCT06542835 is actively recruiting participants. Contact the research team at gdcoronado@arizona.edu for enrollment information.
Where is the NCT06542835 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT06542835 clinical trial?
NCT06542835 is sponsored by University of Arizona. The principal investigator is Anne Escaron, PhD at AltaMed Health Services Corporation. The trial plans to enroll 6,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.